Prenatal testing revenue in the third quarter of 2025 grew 2% year-over-year, reflecting ongoing expansion of payer coverage, particularly for Foresight Expanded Carrier Screen. Prenatal volume over ...

Genetic testing presents major growth opportunities in predictive diagnostics, pharmacogenomic testing, and direct-to-consumer markets. With increasing test volumes and lower prices, the industry is ...

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and ...

The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...

Richard Hammond returns to the driver’s seat for another driving test — years after first passing it. This video follows his ...

Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis ...

Published in the Oct. 30, 2025 edition of Frontiers in Pharmacology, the new post-hoc analysis showed that patients who took the GeneSight test were at any given time during the 24-week study period ...

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.